Fremont, CA, United States of America

Jeremy Thomas Andre Fournier

USPTO Granted Patents = 4 

Average Co-Inventor Count = 20.3

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2022-2025

where 'Filed Patents' based on already Granted Patents

4 patents (USPTO):

Title: The Innovative Contributions of Jeremy Thomas Andre Fournier

Introduction

Jeremy Thomas Andre Fournier, a prominent inventor based in Fremont, California, is known for his significant advancements in the field of medicinal chemistry. With a total of three patents to his name, Fournier is dedicated to developing compounds that aim to address critical health challenges, particularly those associated with cancer and immune-related disorders.

Latest Patents

Fournier's latest patents focus on tetralin and tetrahydroquinoline compounds that serve as inhibitors of HIF-2α (Hypoxia-Inducible Factor 2 Alpha). The patents detail the synthesis methods for these compounds, as well as their potential applications in treating a wide range of diseases and conditions that are mediated by HIF-2α. This work represents a significant step forward in therapeutic strategies aimed at targeting serious health issues.

Career Highlights

Currently, Fournier is associated with Arcus Biosciences, Inc., a company known for its innovative research in cancer therapeutics. His role within the company allows him to contribute to groundbreaking projects that have the potential to impact the medical field significantly.

Collaborations

Throughout his career, Fournier has had the opportunity to collaborate with esteemed colleagues, including Joel Worley Beatty and Samuel Lawrie Drew. Together, they work on advancing research initiatives that seek to enhance the efficacy of treatments related to HIF-2α.

Conclusion

Jeremy Thomas Andre Fournier's contributions to the field of medicinal chemistry are noteworthy, particularly his focus on developing compounds that can potentially revolutionize the treatment of serious medical conditions. With his expertise and commitment to innovation, Fournier continues to be a valuable asset in the world of scientific discovery and healthcare advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…